Auburn studying hepatitis vaccine for canine osteosarcoma

05/9/2013 | AL.com (Alabama)

The Auburn University Research Initiative in Cancer is conducting a study to assess whether a modified hepatitis vaccine can destroy canine cancer cells. Twenty owned dogs with osteosarcoma that have not yet undergone limb amputation will be involved in the study. Researchers hope to use the technique to treat numerous types of cancer in dogs and humans. "Dogs get skin cancer, dogs get blood cancers that are similar to human cancers, dogs get brain cancers ... similar to human cancers ... so what we learn in dogs is very applicable to humans," said veterinarian Bruce Smith, who directs the initiative.

View Full Article in:

AL.com (Alabama)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN